TI
INSY

Turner Investments’s Insys Therapeutics, Inc. INSY Stock Holding History

Turner Investments’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,000
Closed -$581K – 430
2015
Q1 		$581K Buy
20,000
+2,160
+12% +$57.1K 0.1% 214
2014
Q4 		$376K Buy
+17,840
New +$353K 0.04% 372
2014
Q3 		– Sell
-111,460
Closed -$1.74M – 608
2014
Q2 		$1.74M Buy
+111,460
New +$1.8M 0.08% 320

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Turner Investments's INSY Position: Q2 2015 in Review

Turner Investments sold out of Insys Therapeutics, Inc. (INSY) in Q2 2015, closing a stake of 20,000 shares — an estimated $581K sold.

Turner Investments first reported a position in INSY in Q2 2014 and held it in 3 quarters. The position peaked at $1.74M in Q2 2014. 146 funds tracked by Wall St. Rank hold INSY as of Q2 2015.

  • Turner Investments reported no remaining Insys Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Turner Investments sold 20,000 Insys Therapeutics, Inc. shares in Q2 2015, an estimated $581K.
  • Turner Investments first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 3 quarters.
  • Turner Investments's Insys Therapeutics, Inc. position peaked at $1.74M in Q2 2014.
  • 146 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.